Frederick Ueland - Projects & Grants - University of Kentucky

View Scopus Profile

800 Rose Street
40536 Lexington
United States

h-index

Research activity per year

2 Active
31 Finished

33 results

Active
GOG-3020/CO-338-087: ATHENA (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy)
Ueland, F. (PI)
Gynecological Oncology Group Foundation Incorporated
11/30/18 → 12/18/25
Project: Research project
15-GYN-03-GI (CL-PTL-119) Trial of Maintenance FANG
Ueland, F. (PI)
Gradalis Incorporated
8/3/15 → 10/6/25
Project: Research project
Finished

Cell Derived Nanovesicles for Therapeutic Delivery
Kolesar, J. (PI), Arnold, S. (CoI), Bondada, S. (CoI), Richards, C. (CoI) & Ueland, F. (CoI)
XLerate Health LLC
10/1/23 → 2/29/24
Project: Research project
Jill Kolesar Scope: State Matching: Kentucky Network for Innovation & Commercialization (#KYNETIC#) Yr 5
Kolesar, J. (PI), Arnold, S. (CoI), Bondada, S. (CoI), Dwoskin, L. (CoI), Gedaly, R. (CoI), Richards, C. (CoI) & Ueland, F. (CoI)
KY Economic Development Cab
7/1/22 → 6/30/24
Project: Research project
State Matching: Kentucky Network for Innovation & Commercialization (#KYNETIC#) Yr 5
Dwoskin, L. (PI), Arnold, S. (CoI), Bondada, S. (CoI), Lovell, M. (CoI), Prisinzano, T. (CoI), Richards, C. (CoI), Ueland, F. (CoI) & Venditto, V. (CoI)
KY Economic Development Cab
7/1/22 → 6/30/24
Project: Research project
State Matching: Kentucky Network for Innovation & Commercialization (#KYNETIC#) Yr 3
Dwoskin, L. (PI), Arnold, S. (CoI), Bardo, M. (CoI), Bondada, S. (CoI), Fritz, M. (CoI), Guy, R. K. (CoI), Hall, E. (CoI), Kolesar, J. (CoI), McClure, I. (CoI), Richards, C. (CoI), Thorson, J. (CoI), Ueland, F. (CoI), Zhang, G. (CoI), Abdel-Latif, A. (Former CoI), Bruntz, R. (Former CoI), Cassidy, R. (Former CoI), Daugherty, A. (Former CoI), Delisle, B. (Former CoI), Feola, D. (Former CoI), Gabr, M. (Former CoI), Gensel, J. (Former CoI), Gentry, M. (Former CoI), Gordon, S. (Former CoI), Hammill, J. (Former CoI), Leggas, M. (Former CoI), Lima, F. (Former CoI), Lu, H. (Former CoI), Malluche, H. (Former CoI), Rao, M. (Former CoI), Sheppard, M. (Former CoI), Sun, R. (Former CoI), Venditto, V. (Former CoI), Zhan, C.-G. (Former CoI) & Zheng, F. (Former CoI)
KY Economic Development Cab
7/1/20 → 6/30/23
Project: Research project
Jill Kolesar Scope: State Matching: Kentucky Network for Innovation & Commercialization (#KYNETIC#) Yr 3
Kolesar, J. (PI), Bondada, S. (CoI), Dwoskin, L. (CoI), Richards, C. (CoI) & Ueland, F. (CoI)
KY Economic Development Cab
7/1/20 → 4/30/23
Project: Research project
CCSG Pilot: Pulse-dose Lapatinib Combined with Paclitaxel for the Treatment of Recurrent, Platinum-resistant Ovarian Cancer
Ueland, F. (PI), Evers, B. M. (CoI), Kolesar, J. (CoI), Wang, C. (CoI) & Wu, J. (Former CoI)
National Cancer Institute
7/1/20 → 6/30/23
Project: Research project
A Two-Arm, Randomized, Non-Comparative, Phase 2 Trial of AGEN2034 (anti PD-1) as a Monotherapy or Combination Therapy with AGEN1884 (anti-CTLA4) or with Placebo in Women with Recurrent Cervical Cancer (Second Line) - RaPiDS
Ueland, F. (PI)
Gynecological Oncology Group Foundation Incorporated
11/22/19 → 5/23/22
Project: Research project
L.A.U.N.C.H. (Linking and Amplifying User-centered Networks through Connected Health)
Chih, M.-Y. (PI), Baker, C. (CoI), Hourigan, J. (CoI), Huang, B. (CoI), Meyerson, S. (CoI), Mullett, T. (CoI), Stapleton, J. (CoI), Ueland, F. (CoI) & Valentino, J. (CoI)
Westat
10/1/19 → 12/31/20
Project: Research project
The OVAL Study: GOG-3018 (VB-111-701) VB-111: A Randomized, Controlled, Double-Arm, Open-Label, Multip-Center + Paclitaxel v Paclitaxel Monotherapy in Recurrent Platinum-Resistant Ovarian Cancer
Ueland, F. (PI)
Gynecological Oncology Group Foundation Incorporated
12/21/18 → 7/7/23
Project: Research project
GOG-3015/YO39523 Atezolizumab vs. Placebo with Paclitaxel + Carboplatin + Bevacizumab in Ovarian, Fallopian Tube, PPC
Ueland, F. (PI)
Gynecological Oncology Group Foundation Incorporated
11/29/17 → 7/13/23
Project: Research project
A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel with or without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Newly Diagnosed Subjects with Previously Untreated Stages III or IV High-Grade Serious Epithelial Ovarian,
Ueland, F. (PI), Baldwin Branch, L. (CoI), Desimone, C. (CoI) & Miller, R. (CoI)
Gynecological Oncology Group Foundation Incorporated
12/23/15 → 7/4/24
Project: Research project
Cancer Center Support Grant
Evers, B. M. (PI), Adams, V. (CoI), Arnold, S. (CoI), Brouxhon, S. (CoI), Butterfield, D. A. (CoI), Chen, L. (CoI), COHEN, D. (CoI), D'Orazio, J. (CoI), Dignan, M. (CoI), Dressler, E. (CoI), Durbin, E. B. (CoI), Feddock, J. (CoI), Gosky, D. (CoI), Hahn, E. (CoI), Huang, B. (CoI), Lee, E. (CoI), Liu, J. (CoI), Orren, D. (CoI), Plattner, R. (CoI), Rangnekar, V. (CoI), Samayoa, L. (CoI), Shelton, B. (CoI), Shi, Q. (CoI), St Clair, D. (CoI), Thorson, J. (CoI), Tucker, T. (CoI), Ueland, F. (CoI), Vanderford, N. (CoI), Vanderpool, R. (CoI), Wang, C. (CoI), Wang, P. (CoI), Weiss, H. (CoI), Xu, R. (CoI), Zhu, H. (CoI), Cibull, M. (Former CoI), Gal, T. (Former CoI), Hayslip, J. (Former CoI), Horbinski, C. (Former CoI), Liang, Y. (Former CoI), Moscow, J. (Former CoI), Vore, M. (Former CoI) & Wolin, E. (Former CoI)
National Cancer Institute
7/8/13 → 6/30/18
Project: Research project
GOG 3001 - AMG 386 (TRINOVA-3): AMG 386 With Taxol and Carbo as First-line for Stage III-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancers
Ueland, F. (PI)
AMGen
11/2/12 → 1/1/15
Project: Research project
OVA1-PS1-C04 - OVA1# Post Marketing Surveillance Study PS110001
Ueland, F. (PI)
PrecisionMed Inc
4/24/12 → 2/20/14
Project: Research project
OVA2-001-C03: marker Discovery and Clinical Trial Testing for OVA2 using Serum from Women with a Documented Ovarian Adnexal Mass
Ueland, F. (PI)
PrecisionMed Inc
11/17/10 → 11/10/12
Project: Research project
PT-103: Retrospective case Control Study to Develop a Training Set for a Cross Validated Chemoresponse Marker Algorithm in Cases with Ovarian, Peritoneal or Fallopian Tube Cancer
Ueland, F. (PI)
Precision Therapeutics Incorporated
5/6/10 → 4/30/11
Project: Research project
CP12-0711: A Phase 2, Non-randomized, Open-label, Multicenter Study of IMC-1121B in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
Ueland, F. (PI)
ImClone Systems
3/1/09 → 2/28/12
Project: Research project
A Phase III, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gencitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Promary Peritoneal, or Fallopian Tube Carcinoma
Ueland, F. (PI), Depriest, P. (CoI), Desimone, C. (CoI), Miller, R. (CoI), Saunders, B. (CoI) & VanNagell, J. (CoI)
Genentech Inc
9/25/07 → 6/30/14
Project: Research project
CLD2: To Compare the Effect of Different Type BD Vacutainer TUnes on OvaRi Assay
Ueland, F. (PI)
PrecisionMed Inc
3/1/07 → 8/31/08
Project: Research project
CLD3: To Compare Serum Seperation Timepoints at 4C vs Room Temperature Using the Ciphergen OvaRI
Ueland, F. (PI)
PrecisionMed Inc
3/1/07 → 8/31/08
Project: Research project
Whole Blood Protocol for OvaRI Assay Clinical Trial in Women with Ovarian Tumors
Ueland, F. (PI)
PrecisionMed Inc
3/1/07 → 8/31/08
Project: Research project
A Randomized, Double Blind, Placebo-Controlled, Multicenter, 18 week Pilto Study to Investigate the Neuroprotective Effect pg Procrit on the Development of Peripheral Neuropathy in Patients Receiving Chemotherapy for Advanced Ovarian Cancer
Ueland, F. (PI)
Ortho Biotech Inc
11/1/06 → 10/31/09
Project: Research project
A Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy of Partuzumab (rhuMAb 2C4) in Combination with Gencitabine
Ueland, F. (PI)
Genentech Inc
6/1/05 → 12/31/07
Project: Research project
A Phase 2 Study of ET-743 as Second-Line Therapy in Subjects With Persistent or Recurrent Endometrial Carcinoma
Ueland, F. (PI)
Johnson and Johnson
3/27/03 → 2/28/05
Project: Research project
Radomized Trial of High-Dose Versus Conventional Dose Chemotherapy in Patients With Stage III Ovarian Cancer
Ueland, F. (PI)
MD Anderson Cancer Center
2/3/03 → 1/31/06
Project: Research project
A Phase II Study Using Low Dose Radiotherapy as a Chemosensitizer for Adavanced/Persistent Squamous Cell Carcinoma
Malik, U. (PI), Mohiuddin, M. (CoI) & Ueland, F. (CoI)
Bristol Myers Squibb Company
9/5/02 → 2/28/05
Project: Research project
Low Dose Abdonminal Radiotherapy as a Taxotere Chemosensitizer for Recurrent/Persistent or Advanced Ovarian Carcinoma
Mohiuddin, M. (PI) & Ueland, F. (CoI)
Aventis Pharmaceuticals Products Inc
3/1/02 → 4/30/04
Project: Research project
NESP20000220: An Open-Label, Randomized Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects with Nonmyeloid Malignancies Receving Chemotherapy and NESP
Ueland, F. (PI)
AMGen
9/1/01 → 7/31/04
Project: Research project
Gynecologic Oncology Group
Ueland, F. (PI)
Gynecological Oncology Group Foundation Incorporated
7/1/89 → 12/31/13
Project: Research project
A Phase III trial of adjuvant chemotherapy following chemo-radiation as primary treatment for locally advanced cervical cancer compared to chemo-radiation alone: The OUTBACK Trial
Ueland, F. (PI)
Gynecological Oncology Group Foundation Incorporated
7/1/89 → 10/31/14
Project: Research project
Gynecologic Oncology Group
Ueland, F. (PI)
Gynecological Oncology Group Foundation Incorporated
7/1/89 → 3/31/12
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.